FAM32A Inhibitors
FAM32A Inhibitors encompass compounds that intervene in specific signaling pathways and cellular processes to which FAM32A is central. Rapamycin is an inhibitor of mTOR, a critical regulator of cell growth and metabolism. Inhibition of mTOR by rapamycin could impair the function of FAM32A by suppressing the growth signals that FAM32A may enhance, thereby reducing the protein's activity. Similarly, PI3K inhibitors like LY294002 and Wortmannin could attenuate PI3K/AKT signaling pathways, leading to a decrease in FAM32A activity if FAM32A relies on this pathway for its functional role in the cell. AKT-specific inhibitors such as Triciribine would further reduce FAM32A activity directly if AKT phosphorylation regulates FAM32A's function.
Inhibition of the MAPK signaling pathway by PD98059, U0126, SB203580, and SP600125 provides additional routes to suppress FAM32A's functional activity. PD98059 and U0126 specifically target MEK1/2, which are upstream activators of ERK. Decreased activation of ERK would lead to reduced FAM32A activity if it is regulated by ERK signaling. SB203580 and SP600125 target p38 MAPK and JNK, respectively, offering insights into how stress and inflammatory signaling could affect FAM32A activity. Compounds like Torin 1 and AZD8055, which are selective for mTORC1 and mTORC2, would hinder FAM32A activity by impeding the signaling pathways that involve these mTOR complexes. Lastly, SL0101 and PF-4708671 target downstream kinases in the MAPK and mTOR pathways, such as RSK and p70 S6 kinase. If FAM32A is regulated by these kinases, then inhibition by these compounds would lead to a consequent decrease in FAM32A activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is a central regulator of cell growth and metabolism. Given that FAM32A is involved in such cellular processes, rapamycin's inhibition of mTOR can lead to a decrease in FAM32A activity by suppressing the cellular growth signals that FAM32A may be promoting. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, leading to a decreased activation of the downstream AKT signaling pathway. If FAM32A's functional activity is upregulated by AKT signaling, then inhibition by LY294002 would lead to a reduction in FAM32A activity. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits the activation of AKT. If FAM32A is an AKT substrate or is regulated by AKT-mediated signaling, then triciribine's inhibition of AKT can reduce FAM32A activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which is upstream of ERK in the MAPK signaling pathway. If FAM32A is activated by ERK, PD98059's inhibition of MEK would lead to reduced ERK activation and consequently lower FAM32A activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK. If FAM32A's activity is influenced by stress or inflammatory signals transduced by p38, then SB203580's inhibition of p38 MAPK would lead to decreased FAM32A activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, another member of the MAPK family. JNK signaling affects various cellular functions, including those that FAM32A may be involved in, so SP600125's inhibition of JNK can reduce FAM32A activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor, like LY294002. By inhibiting PI3K, Wortmannin can attenuate the PI3K/AKT pathway, potentially reducing FAM32A activity if it relies on PI3K/AKT-mediated signaling for its function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, enzymes upstream of ERK in the MAPK pathway. If FAM32A functions downstream of this pathway, inhibition by U0126 would decrease FAM32A activity by preventing MEK1/2-mediated activation of ERK. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
Torin 1 is a potent mTOR inhibitor that can block both mTORC1 and mTORC2 complexes. Inhibition of these complexes would suppress FAM32A activity if FAM32A is regulated by signaling pathways involving mTOR. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
AZD8055 is a selective inhibitor of both mTORC1 and mTORC2. By inhibiting these mTOR complexes, AZD8055 can lower FAM32A activity if FAM32A's role in the cell is connected to mTOR signaling. | ||||||